The Federal Constitutional Court has dismissed the constitutional complaint lodged by a naturopath against the ban on taking blood for the creation of non-homeopathic autologous blood products. The court in Karlsruhe reported on Tuesday that it could find no breach of her rights. The complainant had challenged administrative and court decisions that prohibited this specific practice.
The core issue revolved around blood collection for so-called native autologous treatments. These procedures involve drawing whole blood from a vein and injecting it unaltered into the muscles. The scope of the complaint also included extended native autologous treatments-where the blood was agitated or mixed with medicines before re-injection-as well as autologous serum therapy, which requires centrifuging the blood to separate the serum.
The challenged decisions were based on the Drug Act and the Transfusion Act, which stipulate that such blood collection must be performed under medical supervision. According to the court, the legislature pursued a “cohesive regulation concept” designed to ensure the integrity and safety of blood products. Furthermore, the court ruled that differentiating between homeopathic and non-homeopathic autologous blood products is factually justified, given that definitive manufacturing guidelines are lacking for the latter (Decision of May 20, 2026 – 1 BvR 2324/24).
